Status:
TERMINATED
Identification of Predictive Markers for Testis Cancer in a Population of Men With High Risk
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Testicular Cancer
Eligibility:
MALE
18-35 years
Phase:
NA
Brief Summary
Testis cancer with germ cells is the most frequent cancer of young men and its incidence is in constant increase in many industrialized countries, as in France. An increased risk of developing testis ...
Eligibility Criteria
Inclusion
- Patients with infertility azoospermia
- Age 18 to 35 years
- Definition of clinical and biological character of azoospermia: testicular volume less than 10 ml and FSH more than 10 IU / l
- Normal karyotype
- Surgical exploration included in a standardized medical aid to procreation
- Testicular biopsy performed by traditional surgery
- Patient informed about the research protocol and having signed consent to conduct a further testicular biopsy included in this study.
Exclusion
- adults protected by law, minors
- Individuals who are not affiliated to a social security
- Subjects hospitalized for any reason other than research.
- Patients will be used to support reproductive techniques:
- Positive serology (HIV, hepatitis ...).
- Patients with karyotype anomalies and unfavourable genetic counselling
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT00820287
Start Date
September 1 2005
End Date
June 1 2011
Last Update
March 26 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice
Nice, France, 06000